HRT Financial’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-49,937
Closed -$497K 3768
2022
Q3
$497K Sell
49,937
-1,125
-2% -$11.2K 0.01% 1568
2022
Q2
$504K Hold
51,062
0.01% 1502
2022
Q1
$501K Hold
51,062
﹤0.01% 1717
2021
Q4
$497K Buy
+51,062
New +$500K ﹤0.01% 1842

HRT Financial's FLAC Position: Q4 2022 in Review

HRT Financial sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 49,937 shares — an estimated $497K sold.

HRT Financial first reported a position in FLAC in Q4 2021 and held it in 4 quarters. The position peaked at $504K in Q2 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

  • HRT Financial reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 49,937 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $497K.
  • HRT Financial first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q4 2021 and held it in 4 quarters.
  • HRT Financial's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $504K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.